RE: RNS today20 Nov 2017 14:30
Following todays RNS , if Sarepta’s intension , following their recent fund raising, was to effectively acquire the remaining world wide rights to DMD, i can not see them waiting until the end of Q1 2018 , to make their move, given Summits current market cap.We will have to wait and see.D